Table 3 Comparison of outcomes for patients who successfully suppressed viremia to <1000cp/ml with patients who were unable to suppress viral replication while on treatment

Gender:

Male

23

30

At initiation:

Age, years, median (IQR)

6.9 (4.4-9.8)

7.1 (3.2-9.6)

Viral load, log₁₀ cp/ml, median (IQR)

3.8 (3.4-4.7)

4.2 (3.7-4.7)

CD4, cells/μl, median (IQR)

290 (136–563)

281 (89–560)

Regimen

3TC-D4T-EFV

33

31

3TC-D4T-LPV/r

6

6

3TC-ABC-EFV

1

7

3TC-ABC-LPV/r

0

4

3TC-AZT-EFV

1

0

At genotyping:

Age, years, median (IQR)*

11.1 (8.5-13.1)

9.8 (5.6-12.3)